Human GREM1/DAND2 Antibody, In
Vivo Block/Neutralizing Antibody-Human GREM1/DAND2 Antibody, InVivo Block/Neutralizing Antibody- 询价
- Biogradetech
- 美国
- BGT-ANT-37347
- 2025年07月11日
- ELISA,In vivo Neutralization,FCM
- Human
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 免疫原：
免疫原详情见datasheet，该抗体亚型为：IgG4, kappa
- 保存条件：
-2°C-8°C
- 保质期：
1年
- 库存：
100
- 供应商：
艾美捷科技
- 宿主：
Human
- 应用范围：
ELISA,In vivo Neutralization,FCM
- 抗体英文名：
Human GREM1/DAND2 Antibody, InVivo Block/Neutralizing Antibody
- 抗体名：
Human GREM1/DAND2 Antibody, InVivo Block/Neutralizing Antibody
Human GREM1/DAND2 Antibody, InVivo Block/Neutralizing Antibody，Human GREM1/DAND2 Antibody, InVivo Block/Neutralizing Antibody，Human GREM1/DAND2 Antibody, InVivo Block/Neutralizing Antibody,Human GREM1/DAND2 Antibody, InVivo Block/Neutralizing Antibody
产品名称：Human GREM1/DAND2 Antibody, InVivo Block/Neutralizing Antibody-Human GREM1/DAND2 Antibody, InVivo Block/Neutralizing Antibody
产品货号：BGT-ANT-37347
产品规格：100ug#1mg
应用类型：ELISA,In vivo Neutralization,FCM
蛋白别名：Cysteine knot superfamily 1, BMP antagonist 1, CKTSF1B1, Down-regulated in Mos-transformed cells protein, Increased in high glucose protein 2, IHG-2, DRM, GREM1, Gremlin-1, Cell proliferation-inducing gene 2 protein, DAN domain family member 2, DAND2
Human GREM1/DAND2 Antibody, InVivo Block/Neutralizing Antibody-Human GREM1/DAND2 Antibody, InVivo Block/Neutralizing Antibody详情见产品datasheet
点击：Human GREM1/DAND2 Antibody, InVivo Block/Neutralizing Antibody-Human GREM1/DAND2 Antibody, InVivo Block/Neutralizing Antibody更多Biogradetech产品信息价格，货期，产品说明，百度搜“艾美捷科技”进入官网网站，查看具体产品且快速下单。
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验ANTIBODY BINDING TO PROTEIN A AND PROTEIN G
Table I Species Protein A Protein G Human ++++ ++++ Mouse ++ ++ Rat
Human Antibody Production Using Insect-Cell Expression Systems
protein modifications (e.g., glycosylation) provided by mammalian expression systems are not evident for insect cell-expressed antibodies, these differences do not affect important Ig activities, including complement lysis activity and antibody-dependent
Antibodies elicited by passive or active immunization protect against numerous virus diseases. This in vivo protective immunity is often associated with in vitro detection of neutralizing antibodies (NAb) (e.g., polio, measles, influenza
技术资料暂无技术资料 索取技术资料
